Upstream Bio announces Phase 3 plans for Verekitug in two indications
Upstream Bio said it has pivotal Phase 3 development plans for Verekitug in severe asthma and CRSwNP.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Upstream Bio said it has pivotal Phase 3 development plans for Verekitug in severe asthma and CRSwNP.